toll free: 1800 3070 6727 Email: firstname.lastname@example.org
Newly diagnosed Prostate Cancer Patients
Prostate cancer patients who have recently undergone Radical Prostatectomy
Determine the aggressiveness of Prostate Cancer
In newly diagnosed: Find out surgery is required or not; In post radical prostatectomy setting: Find out adjuvant radiotheray is required or not
Sample Requirement: FFPE Blocks
CAP & CLIA certified laboratory
Reporting time: 3 weeks
Download sample report
Prolaris is a genomic test helps in predicting prostate cancer aggressiveness in conjunction with clinical parameters such as Gleason score and PSA. Prolaris is the first prognostic test that offers a direct measure of the molecular biology of an individual patient’s prostate cancer. Undergoing the Prolaris test will help a patient determine if they require surgery, chemotherapy or if active monitoring is enough.
On my diagnosis of Prostate cancer i was advised Prostatectomy by a doctor. After hearing the side effects of surgery like incontinence i was really stressed and scared. Then i ordered Prolaris which revealed that i have a considerably less aggressive Prostate Cancer and thus I dont need to undergo Prostatectomy. Prolaris reports came as a huge relief for me.
I underwent prostatectomy. Post surgery my doctor wasnot sure whether i need adjuvant radation therapy or not as it depends on how likely the cancer will come back. My doctor prescribed me Prolaris which revealed that chances of biochemical recurrence in me is very low. I could avoid unwarranted adjuvant therapy and treatment cost only because of Prolaris.
Better understand a patients’ risk for specific health conditions
Prescribe more suitable medications at optimal dosages for patients, as needed.
Suggest early lifestyle and diet interventions to help control or prevent certain health conditions.
31% more accurate in identifying cancer driver mutations
Better treatment recommendation
Complementary consultation with your doctor
Best treatment recommendation
Provides information on pathway analysis
Includes Positive Bioscience expert comments and complementary consultation with your doctor
Industry leading 51 gene tes
Learn your risk for 11 cancers
Know risk to secondary cancers in cancer patients
533, Kalbadevi Road,
Mumbai – 400002